The mechanism of the interaction of singlet excited
dibenzoyl(methanato)boron difluoride (*DBMBF2
=
*A) with olefins and substituted benzenes (SB) was investigated by the
determination of effective quenching distances
(R
eff) from fluorescence monitors in
acetonitrile as analyzed by the Smoluchowski−Collins−Kimball
equation and
by solvent effects on the dichotomy of the formation of cycloadducts
and [4 + 2] dimers from 1,3-cyclohexadiene
(CHD) and 1,3-cyclooctadiene (1,3-COD). The correlation of
R
eff with
directly demonstrates that the reactants
have to get closer to affect electron transfer from these substrates as
the driving force become more positive and
coalesce on exciplexes. Both photophysical and photochemical
probes converge on the partition of encounter pairs
to the SSRIP (the k
et pathway which leads to
radical ion reactions and nonfluorescent) and exciplexes (the
k
ex pathway
which leads to cycloadducts and fluorescent species); the former
pathway was promoted by low redox energies of
donor−acceptor pairs and by high solvent polarity. The reaction
with 1,3-cylcohexadiene gave high quantum yields
of the [4 + 2] dimers in acetonitrile and of the cycloadduct in
nonpolar solvents; the latter quantum yields were
correlated with the solvent polarity parameter
E
T(30) in a smooth distribution regardless
of pure non-SB or SB
solvents or mixture solvents (including benzene), in spite of the fact
that the reactive intermediates in the presence
of SB are *DBMBF2−SB exciplexes. It is proposed that
in the exciplex the locally excited state provides the
driving
force in the cycloaddition and the CT state regulates its
regiospecificity. The quantum yield of the dimers
from
CHD was greatly enhanced, reaching their maximum at 12 mol % of
p-xylene in acetonitrile; the enhancement was
attenuated with the addition of toluene and benzene in that order.
This shows that the p-xylene exciplex
underwent
extraordinary facile substitution with CHD by electron transfer in
acetonitrile probably promoted by superexchange
interactions. The *DBMBF2 excimer reacted with CHD and
1,3-COD to give higher yields of cycloadducts but not
the dimers, which must mean that the excimer substitution with CHD
proceeds to give the new exciplex but not the
radical ion pair. The latter failure as well as that of the
benzene exciplex was suggested to arise from the
insignificant
CT content of the excimer and exciplex. The frontier MO scheme was
utilized to rationalize the enhanced reactivity
of the exciplexes and excimer on the bases of increased electronic and
orbital interactions, respectively.
YUAN L. CHOW, SHI-SEN WANG, and XIAN-EN CHENG. Can. J. Chem. 71, 846 (1993). Dibenzoylmethanatoboron difluoride (DBMBF,), the BF, complex of dibenzoylmethane, reacted from its singlet excited state with a,P-unsaturated ketones and esters to give 1,5-diketones by a [2+2] cycloaddition and ring-opening sequence in an analogous pathway to that observed in the photocycloaddition to olefins and dienes. The present photoreaction is unexpected since conjugated enones and en-esters are poor electron donors to comply with the previously proposed charge transfer requirement in DBMBF, photoreactions. The photocycloaddition to these substrates was highly regioselective and stereoselective, giving the head-to-head orientation, which could be enhanced by a-methyl substitution; P-methyl substitution increased the alternate head-to-tail orientation. The photolysis of a mixture of DBMBF, and a cyclic enone also caused the latter to dimerize to give head-to-head and head-to-tail dimers in significant yields. These photodimerizations were apparently caused by DBMBF, sensitization. The mechanism of the sensitization is discussed. [Traduit par la rCdaction1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.